GSK
GSK·NYSE
--
--(--)
--
--(--)
4.61 / 10
Netural
Fund flow analysis scores 7.82/10, reflecting robust inflows, particularly in small and extra-large categories, despite challenges in medium and large flows. Analyst sentiment is overwhelmingly bearish with a 100% sell rating from one analyst, supporting a cautious view.
Fund Flow Rating
Analyst RatingSell
Wall Street Opinions
Sell
Strong Buy
0%
Buy
0%
Hold
0%
Sell
100%
Strong Sell
0%
Date2026-01-06
InstitutionBarclays
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of GSK?
- GSK holds a Bearish analyst rating, with 100% of experts assigning a Sell grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.61/10 (Netural).
